12:00 AM
 | 
Sep 15, 2008
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Heptares Therapeutics Ltd.

London, U.K.

Technology: StaR GPCR stabilization technology

Disease focus: Neurology, endocrine

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >